- Home
- TOVX vs UOKA Comparison
TOVX vs UOKA Comparison
Compare TOVX & UOKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOVX
- UOKA
- Stock Information
- Founded
- TOVX 2001
- UOKA 2002
- Country
- TOVX United States
- UOKA United Kingdom
- Employees
- TOVX N/A
- UOKA N/A
- Industry
- TOVX Biotechnology: Pharmaceutical Preparations
- UOKA
- Sector
- TOVX Health Care
- UOKA
- Exchange
- TOVX Nasdaq
- UOKA NYSE
- Market Cap
- TOVX 3.5M
- UOKA 3.7M
- IPO Year
- TOVX 2006
- UOKA N/A
- Fundamental
- Price
- TOVX $1.21
- UOKA $0.27
- Analyst Decision
- TOVX Strong Buy
- UOKA
- Analyst Count
- TOVX 1
- UOKA 0
- Target Price
- TOVX $6.00
- UOKA N/A
- AVG Volume (30 Days)
- TOVX 102.1K
- UOKA 15.4M
- Earning Date
- TOVX 11-12-2024
- UOKA 02-16-2025
- Dividend Yield
- TOVX N/A
- UOKA N/A
- EPS Growth
- TOVX N/A
- UOKA N/A
- EPS
- TOVX N/A
- UOKA N/A
- Revenue
- TOVX N/A
- UOKA $114,849.00
- Revenue This Year
- TOVX N/A
- UOKA N/A
- Revenue Next Year
- TOVX N/A
- UOKA N/A
- P/E Ratio
- TOVX N/A
- UOKA N/A
- Revenue Growth
- TOVX N/A
- UOKA 289.97
- 52 Week Low
- TOVX $1.14
- UOKA $0.14
- 52 Week High
- TOVX $17.00
- UOKA $1.90
- Technical
- Relative Strength Index (RSI)
- TOVX 37.37
- UOKA N/A
- Support Level
- TOVX $1.15
- UOKA N/A
- Resistance Level
- TOVX $1.34
- UOKA N/A
- Average True Range (ATR)
- TOVX 0.07
- UOKA 0.00
- MACD
- TOVX 0.01
- UOKA 0.00
- Stochastic Oscillator
- TOVX 7.41
- UOKA 0.00
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
About UOKA MDJM LTD
MDJM Ltd is a real estate service company. The company provides real estate agency services to real estate developer clients, as well as real estate consulting services and independent training services on an as-needed basis. It offers consulting, marketing planning, advertising services, and sales strategies to real estate clients. The company income is derived from commission-based services and minimal consulting and other services. The company has two operating segments; the real estate agent services segment and the hospitality business segment. It derives a majority of its revenue from the People's Republic of China.